ANDRINI, ELISA
 Distribuzione geografica
Continente #
AS - Asia 1.507
NA - Nord America 663
EU - Europa 612
AF - Africa 77
SA - Sud America 65
OC - Oceania 4
Totale 2.928
Nazione #
US - Stati Uniti d'America 645
CN - Cina 509
SG - Singapore 440
IT - Italia 252
VN - Vietnam 213
HK - Hong Kong 130
KR - Corea 99
DE - Germania 67
NL - Olanda 57
IN - India 54
SE - Svezia 53
BR - Brasile 48
GB - Regno Unito 35
IE - Irlanda 31
CI - Costa d'Avorio 30
FI - Finlandia 29
CH - Svizzera 24
RU - Federazione Russa 21
TG - Togo 21
JP - Giappone 19
JO - Giordania 13
SC - Seychelles 13
CA - Canada 11
FR - Francia 11
ID - Indonesia 11
AT - Austria 10
BG - Bulgaria 10
MX - Messico 6
AR - Argentina 5
BD - Bangladesh 5
PL - Polonia 5
AU - Australia 4
EC - Ecuador 4
EG - Egitto 3
LB - Libano 3
NG - Nigeria 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
CO - Colombia 2
LT - Lituania 2
TR - Turchia 2
TW - Taiwan 2
AZ - Azerbaigian 1
CL - Cile 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GF - Guiana Francese 1
HU - Ungheria 1
IL - Israele 1
KE - Kenya 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MY - Malesia 1
PE - Perù 1
PK - Pakistan 1
PY - Paraguay 1
RS - Serbia 1
SA - Arabia Saudita 1
SN - Senegal 1
SR - Suriname 1
TN - Tunisia 1
VE - Venezuela 1
Totale 2.928
Città #
Singapore 302
Hefei 215
Ashburn 161
Hong Kong 128
Seoul 99
Santa Clara 74
Bologna 55
Ho Chi Minh City 55
Beijing 53
Hanoi 51
Chandler 34
Boardman 33
Dublin 31
Abidjan 30
Dong Ket 24
Milan 23
Bern 22
Fairfield 22
Lomé 21
Bengaluru 19
Dallas 19
Helsinki 19
Tokyo 19
Vicenza 19
Los Angeles 18
Munich 16
Amman 13
Buffalo 13
Southend 13
Biên Hòa 12
Turin 12
Hyderabad 11
Shanghai 10
Sofia 10
Princeton 9
Redondo Beach 9
Tongling 9
Falkenstein 8
New York 8
Nuremberg 8
Woodbridge 8
Frankfurt am Main 7
Guangzhou 7
Haiphong 7
Jakarta 7
Lappeenranta 7
Seattle 7
Brooklyn 6
Chicago 6
Ha Long 6
Houston 6
São Paulo 6
Amsterdam 5
Da Nang 5
Düsseldorf 5
London 5
Mexico City 5
Montreal 5
Rome 5
Tianjin 5
Vienna 5
Wilmington 5
Hải Dương 4
Modena 4
Phoenix 4
Poplar 4
Redmond 4
Thu Dau Mot 4
Warsaw 4
Brasília 3
Bristol 3
Cambridge 3
Council Bluffs 3
Elk Grove Village 3
Ferrara 3
Florence 3
Genoa 3
Hangzhou 3
Harbin 3
Lấp Vò 3
Moncalieri 3
Mumbai 3
Ninh Bình 3
Palermo 3
Salerno 3
Taranto 3
Turku 3
Visakhapatnam 3
Wuhan 3
Xi'an 3
Abeokuta 2
Atlanta 2
Barbianello 2
Bonate Sopra 2
Boydton 2
Brisbane 2
Brunswick 2
Bắc Giang 2
Can Tho 2
Caraglio 2
Totale 1.948
Nome #
A phase II, open-label, single arm, trial of carboplatin plus etoposide with bevacizumab and atezolizumab in patients with extended-stage small-cell lung cancer (CeLEBrATE study): background, design and rationale 201
Chemotherapy in Well Differentiated Neuroendocrine Tumors (NET) G1, G2, and G3: A Narrative Review 164
Beyond EGFR, ALK and ROS1: Current evidence and future perspectives on newly targetable oncogenic drivers in lung adenocarcinoma 161
The mechanisms of PD-L1 regulation in non-small-cell lung cancer (NSCLC): Which are the involved players? 152
Bone targeting agents in patients with metastatic prostate cancer: State of the art 139
Immune checkpoint inhibitors in lung tumors with rare histologies and other thoracic malignancies 138
Real-Life Use of [68Ga]Ga-DOTANOC PET/CT in Confirmed and Suspected NETs from a Prospective 5-Year Electronic Archive at an ENETS Center of Excellence: More Than 2000 Scans in More Than 1500 Patients 135
Prospective Evaluation of MGMT-Promoter Methylation Status and Correlations with Outcomes to Temozolomide-Based Chemotherapy in Well-Differentiated Neuroendocrine Tumors 127
Prognostic Factors of Survival for High-Grade Neuroendocrine Neoplasia of the Bladder: A SEER Database Analysis 126
Peripheral nervous system adverse events associated with immune checkpoint inhibitors 120
An Update on Appendiceal Neuroendocrine Tumors 118
Single-agent carboplatin in extensive disease small-cell lung cancer patient with liver failure: A case report within the experience of a single institution 117
Multimodal strategy in localized merkel cell carcinoma: Where are we and where are we heading? 116
Endoscopic Ultrasound-Guided Locoregional Treatments for Pancreatic Neuroendocrine Neoplasms 105
Sequencing Treatments in Patients with Advanced Well-Differentiated Pancreatic Neuroendocrine Tumor (pNET): Results from a Large Multicenter Italian Cohort 104
Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinations 103
Large Cell Neuroendocrine Carcinoma of the Lung: Current Understanding and Challenges 95
Targeted Genomic Profiling and Chemotherapy Outcomes in Grade 3 Gastro-Entero-Pancreatic Neuroendocrine Tumors (G3 GEP-NET) 91
Lymph node ratio predicts efficacy of postoperative radiation therapy in nonmetastatic Merkel cell carcinoma: A population-based analysis 79
β1600 Q.Clear Digital Reconstruction of [68Ga]Ga-DOTANOC PET/CT Improves Image Quality in NET Patients 68
Challenges in the management of advanced NSCLC among Italian oncologists: a 2019 national survey unfolds regional disparities 60
Challenges and future perspectives for the use of temozolomide in the treatment of SCLC 58
Advanced non-small-cell lung cancer: how to manage EGFR and HER2 exon 20 insertion mutation-positive disease 54
BRAF V600E-mutated large cell neuroendocrine carcinoma responding to targeted therapy: A case report and review of the literature 54
Non-small-cell lung cancer: how to manage RET-positive disease 52
How to manage KRAS G12C-mutated advanced non-small-cell lung cancer 51
Targeting DNA damage response and repair genes to enhance anticancer immunotherapy: Rationale and clinical implication 41
Antibody–drug conjugates for lung cancer in the era of personalized oncology 41
Treatment Patterns and Clinical Outcomes Among Patients With ROS1-rearranged Non–small-cell Lung Cancer Progressing on Crizotinib 39
Omitting hemicolectomy for patients with appendiceal neuroendocrine tumours of 1-2 cm 37
Impact of performance status and age on osimertinib efficacy in patients with EGFR-mutant T790M-positive non-small-cell lung cancer 25
Classic versus innovative strategies for immuno-therapy in pancreatic cancer 18
Safety and cost-effectiveness of immediate right hemicolectomy versus active surveillance for well-differentiated appendiceal neuroendocrine tumors 1-2 cm in size: a Markov decision analysis 14
Totale 3.003
Categoria #
all - tutte 9.443
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.443


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202179 0 0 0 0 0 10 22 5 3 5 6 28
2021/2022110 0 0 2 4 8 3 3 19 10 6 40 15
2022/2023346 12 28 8 13 15 25 30 32 73 25 34 51
2023/2024158 9 17 6 12 9 35 13 19 6 16 9 7
2024/2025939 49 56 76 64 119 54 61 44 25 82 86 223
2025/20261.337 269 396 190 189 203 90 0 0 0 0 0 0
Totale 3.003